insilTox ApS: Financial statements 2022
CVR: 36996641
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
insilTox ApS (CVR 36996641) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 139,632 and a net result of DKK 2,786 compared with DKK -27,598 the year before. That is an increase of 78.4% compared with the year before. Equity in the 2022 report amounted to DKK 47,336. The solvency ratio was 62.1%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 139,632
- Profit/Loss
- DKK 2,786
- Equity
- DKK 47,336
- Total Assets
- DKK 76,207
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 140K | 3K | 47K | 1 |
| 2021 | - | 78K | -28K | 45K | 1 |
| 2020 | - | 137K | 43K | 72K | 1 |
| 2019 | - | 199K | -38K | 29K | 1 |
| 2018 | - | 123K | 5K | 67K | 1 |
Official annual report
Keep an eye on insilTox ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
InsilTox ApS has published its annual report for 2021. Gross profit came to DKK 78,281, and the net result was DKK -27,598.
About insilTox ApS
insilTox ApS is a Danish company of the type Anpartsselskab based in Kgs. Lyngby, founded in 2015. The company is registered under the industry Anden teknisk rådgivning. The management consists of Svava Osk Jonsdottir. The company is owned by insilTox Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 158,376 and a net result of DKK 3,502 compared with DKK 3,861 the year before. Equity in the 2025 report amounted to DKK 46,998.